In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed decisions.

Show Notes
1) Tools for Practice
Preventing RSV Infections in Infants

2) MAKING EVIDENCE MATTER for EVERYONE CONFERENCE
Vancouver
May 24/25, 2024
https://hectalks.com

In episode 571, James and Mike talk about 2 new papers – we learn what antibiotics we can use for community-acquired pneumonia and we also talk about the prevalence and management of dyslipidemia in Canadian primary care practices and find out who has this problem and who gets treated.

Show Notes
Identifying the Best Initial Oral Antibiotics for Adults with Community‐Acquired Pneumonia: A Network Meta‐Analysis
J Gen Intern Med. 2024 Feb 15.doi: 10.1007/s11606-024-08674-1.

Prevalence and management of dyslipidemia in primary care practices in Canada
Can Fam Physician. 2024 Mar;70(3):187-196.doi: 10.46747/cfp.7003187

In episode 570, James and Mike finish their trilogy on statistics. We take what we discussed in the previous podcasts and go through a couple of examples that will hopefully solidify what all the terms and numbers really mean.

Show Notes
1) Sensible Medicine
Doing statistics can be difficult but understanding them can be fairly simple
2) Analysis of 567,758 randomized controlled trials published over 30 years reveals trends in phrases used to discuss results that do not reach statistical significance
PLoS Biol 2022: e3001562. https:// doi.org/10.1371/journal.pbio.3001562